Pyromania

Single nucleotide polymorphisms (SNPs) are the most common type of sequence variation in the human genome. These single-base variations at key sites in DNA are believed to be associated with susceptibility to certain diseases and differential response to pharmaceutical therapies. The detection and analysis of SNPs have typically relied on Sanger sequencing and electrophoresis for genomewide studies or hybridization-based methods whose accuracy may be inadequate. Pyrosequencing reads SNPs by che

Written byHilary Sussman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Single nucleotide polymorphisms (SNPs) are the most common type of sequence variation in the human genome. These single-base variations at key sites in DNA are believed to be associated with susceptibility to certain diseases and differential response to pharmaceutical therapies. The detection and analysis of SNPs have typically relied on Sanger sequencing and electrophoresis for genomewide studies or hybridization-based methods whose accuracy may be inadequate.

Pyrosequencing reads SNPs by chemiluminescence Now Pyrosequencing AB of Uppsala, Sweden, offers a new sequencing technology for the genotyping of SNPs with greater than 99 percent accuracy. In the Pyrosequencing™ system, immobilized single-stranded DNA template-sequencing primer hybrids are incubated with enzymes and substrates provided in the SNP reagent kit. The unit then adds each of four dNTPs to the reaction one at a time; DNA polymerase will only catalyze incorporation of the nucleotide complementary to the next base in the template, releasing pyrophosphate (PPi). ATP ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies